Alastair Smith Insider Profile
4 Followers
Alastair Smith, Director at Evgen Pharma, holds 36.21M shares in Evgen Pharma (Ticker: GB:TCF), holds ― shares in N4 Pharma (Ticker: GB:THAT), holds 451.10K shares in Avacta Group plc (Ticker: GB:AVCT). Most recently, Alastair Smith Bought ― shares of Evgen Pharma on Aug 20, 2026 for an estimated value of 25.00K .
Alastair Smith's Trading History
You May Also Like
Alastair Smith insider profile FAQ
What is the percentage of profitable transactions made by Alastair Smith?
The percentage of profitable transactions made by Alastair Smith is 30%.
What is the average return per transaction made by Alastair Smith?
The average return per transaction made by Alastair Smith is 68.30%.
What stocks does Alastair Smith hold?
Alastair Smith holds: GB:TCF, GB:AVCT, GB:THAT stocks.
What was Alastair Smith’s latest transaction?
Alastair Smith’s latest transaction was an Informative Buy of 25.00K .
What was Alastair Smith's most profitable transaction?
Alastair Smith’s most profitable transaction was an Informative Buy of GB:AVCT stock on October 18, 2019. The return on the trade was 800.00%.
What is Alastair Smith's role in Evgen Pharma?
Alastair Smith's role in Evgen Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.